Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

OBJECTIVE To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. METHODS A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. RESULTS The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall well-being, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P < .001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P < .001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P < .001]) in the patients compared with controls. CONCLUSIONS The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.

[1]  R. Harwood,et al.  Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial , 2004, British Journal of Ophthalmology.

[2]  Benita J. O’Colmain,et al.  Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.

[3]  A. Ramé [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[4]  A. Lindblad,et al.  Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. , 2005, Archives of ophthalmology.

[5]  R. Hays,et al.  Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators , 1998 .

[6]  Jill Carlton,et al.  The impact of age-related macular degeneration on health status utility values. , 2005, Investigative ophthalmology & visual science.

[7]  W. Feuer,et al.  Quality of life of low-vision patients and the impact of low-vision services. , 1999, American journal of ophthalmology.

[8]  Gary C. Brown,et al.  Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. , 2003, Ophthalmology.

[9]  G. Huston The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[10]  E. Bass,et al.  Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. , 2004, American journal of ophthalmology.

[11]  Stuart I. Brown,et al.  The psychosocial impact of macular degeneration. , 1998, Archives of ophthalmology.

[12]  S. Cummings,et al.  Higher risk of multiple falls among elderly women who lose visual acuity. , 2004, Ophthalmology.

[13]  E. Bass,et al.  Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. , 2004, Archives of ophthalmology.

[14]  A Hofman,et al.  Epidemiology of age-related maculopathy. , 1995, Epidemiologic reviews.

[15]  P. Mitchell,et al.  Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study. , 2004, Investigative ophthalmology & visual science.

[16]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[17]  R. Hays,et al.  Development of the 25-item National Eye Institute Visual Function Questionnaire. , 2001 .

[18]  M. Mulvihill,et al.  The prevalence of eye disease in nursing home and non-nursing home geriatric populations. , 1999, Archives of gerontology and geriatrics.

[19]  R P Murphy,et al.  Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. , 1982, American journal of ophthalmology.

[20]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[21]  F. Ferris,et al.  Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.

[22]  P. Jong Prevalence of age-related macular degeneration in the United States. , 2004 .

[23]  I. Scott FALLS AND HEALTH STATUS IN ELDERLY WOMEN FOLLOWING FIRST EYE CATARACT SURGERY: A RANDOMIZED CONTROLLED TRIAL , 2005 .

[24]  R. Harwood Visual problems and falls. , 2001, Age and ageing.

[25]  J E Keeffe,et al.  Impact of age related macular degeneration on quality of life , 2006, British Journal of Ophthalmology.

[26]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[27]  E. Bass,et al.  Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1. , 2003, Archives of ophthalmology.

[28]  A. Kasuya EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.